Full Answer
Why did Regeneron donate money to a non-profit?
Still no. Here’s what Regeneron did: It donated money to a nonprofit patient assistance foundation — a disappointingly necessary and common practice — so the foundation could help patients afford their copays on a medically necessary treatment that staves off blindness. Regeneron was, essentially and entirely, simply paying Medicare.
What is the Patient Assistance Support Program (pass)?
The Patient Assistance Support program, PASS (the “Program”), is an assistance program supported by Regeneron Pharmaceuticals, Inc., and its aliates and agents that provides qualifying patients with Regeneron products at no cost. Authorization to Disclose Information:
How many FDA-approved medicines does Regeneron have?
Our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved medicines for people with serious diseases. Unlike at many other biopharma companies, all these medicines were invented in our own laboratories and advanced under the consistent guidance of the Regeneron team.
See more
What diseases is Regeneron used for?
Our clinical portfolio currently includes antibody candidates for over 30 types of cancer, including cutaneous squamous cell carcinoma, basal cell carcinoma, non-small cell lung cancer, cervical, diffuse large B-cell lymphoma, follicular lymphoma, multiple myeloma, ovarian, prostate cancers and many more.
How do you request Regeneron?
To request infusion of monoclonal antibodies and a medical team at your facility, you may call the 24-hour State Infusion Hotline at 1- 800- 742- 5990. An Infusion Specialist will record your information and process your request.
What is unique about Regeneron?
One of the things that's made Regeneron really unique is its willingness to invest in cutting edge technologies. We're one of the few companies in the world that go all the way from foundational discovery, to research, from research to development, to manufacturing and commercialization.
How do I contact Regeneron?
Medical inquiries Healthcare professionals, patients or caregivers may request specific product information, report an adverse event or report a product complaint for a Regeneron product to our Medical Information Department. Please call 1-844-REGN-MID (1-844-734-6643) for further information.
Can anyone get Regeneron for Covid?
The U.S. Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for REGEN-COV® (casirivimab and imdevimab) for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of ...
How soon should I get Regeneron?
Casirivimab and imdevimab should be given together as soon as possible after positive results of direct SARS-CoV-2 viral testing and within 10 days of symptom onset.
Can Regeneron make Covid worse?
Monoclonal antibodies, such as REGENCOV, may be associated with worse clinical outcomes when administered to hospitalized patients with COVID-19 requiring high flow oxygen or mechanical ventilation. institutional setting (for example, nursing home or prisons).
Can monoclonal antibodies make Covid worse?
Some possible risks from antibody treatment are: It may interfere with your body's ability to fight off a future infection of COVID-19. It may reduce your body's immune response to a vaccine for COVID-19.
How long does the Regeneron infusion last?
If you are receiving an intravenous infusion, the infusion will take 20 to 50 minutes or longer. o After the initial dose, if your healthcare provider determines that you need to receive additional doses of REGEN-COV for ongoing protection, the additional intravenous or subcutaneous doses would be administered monthly.
Does Regeneron pay well?
Salaries at Regeneron Inc range from an average of $59,332 to $173,077 a year. Regeneron Inc employees with the job title Research Scientist make the most with an average annual salary of $101,422, while employees with the title Research Associate, Biotechnology make the least with an average annual salary of $73,273.
Is Regeneron a good company?
Regeneron Ranked #1 Biopharma Employer for Sixth Time by Science Magazine. Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Science magazine has named the company the world's number one employer in its annual survey of the biotech and pharmaceutical industry.
Is Regeneron fully approved?
Regeneron's bid for COVID-19 drug's full approval hits snag as FDA extends review.
What is the cost for Regeneron?
Under the new agreement, Regeneron will supply an additional 1.4 million 1,200 mg doses of REGEN-COV to the U.S. government by January 31, 2022 , at a cost of $2,100 per dose.
Is Regeneron given to hospitalized patients?
REGEN-COV is not authorized for use in patients: who are hospitalized due to COVID-19, or • who require oxygen therapy due to COVID-19, or • who require an increase in baseline oxygen flow rate due to COVID-19 in those on chronic oxygen therapy due to underlying non-COVID-19 related comorbidity.
Who can get Regeneron in Florida?
This treatment is available to all eligible people, regardless of vaccination status.Older age (65 years of age and older)Individuals overweight.Chronic kidney disease.Diabetes.Pregnancy.Immunosuppressive disease or treatments.Cardiovascular disease.Chronic lung diseases.More items...•
Is Regeneron fully approved?
Regeneron's bid for COVID-19 drug's full approval hits snag as FDA extends review.
What is Regeneron's belief?
We believe that patients should have access to appropriate, evidence-based medicines to get them to the best health. Patients are singularly able to tell their story about access challenges and how these obstacles can impact their daily lives and health. Regeneron has supported advocacy training, distribution of access tools, town halls and coalition building for patients and caregivers so that they can have a greater chance for successful outcomes. To submit a request for funding, visit our grants portal.
What is compassionate use policy?
Our Compassionate Use Policy gives certain patients who have serious or life-threatening conditions access to a potentially beneficial medicine when no comparable or satisfactory alternative therapy options or clinical trials area available. Compassionate Use, also known as expanded access in the U.S., is an approved pathway that, by design, is meant for exceptional circumstances. Our Compassionate Use program has certain established criteria and each request is reviewed by Regeneron’s Compassionate Use Committee.
Is Regeneron a fast response?
To address emerging or rapidly spreading infectious diseases, Regeneron has applied our VelociSuite ® technologies in a ‘rapid response’ manner that parallel tracks certain steps and speeds hand-offs between groups in order to advance novel antibody treatments extremely quickly. We’ve been proud to apply our homegrown technologies and novel scientific approach to respond to public health challenges like Ebola, Middle East Respiratory Syndrome (MERS) and COVID-19.
What is the extra help program?from praluent.com
It's called the Extra Help Program and it offers: Reduced Medicare Part D premiums. No cost share in the coverage gap or "donut hole". Lower drug copays.
How long does it take for a patient to get reimbursement for a copay?from praluenthcp.com
Patients can submit for reimbursement if they paid their copay in full within 90 days. || Eligible patients with commercial insurance not funded through a government healthcare. program such as Medicare, Medicaid, or TRICARE are subject to program terms and restrictions.
What is step therapy override?from praluent.com
Some states have laws called “step therapy override legislation” that may help certain people get access to specialty medications like PRALUENT. Not sure about the drug coverage in your state? You can find your state’s National Association of Insurance Commissioners contact information here.
What to know before submitting documentation to health plan?from praluenthcp.com
Before submitting any documentation to the health plan, be sure that it’s accurate and up to date to avoid unnecessary denials.
Do you need a PA for paluent?from praluenthcp.com
Many health plans require a PA for PRALUENT. Here are some helpful tips to keep in mind when gathering your patient’s clinical information and preparing a PA submission.
What did Regeneron do?
Here’s what Regeneron did: It donated money to a nonprofit patient assistance foundation — a disappointingly necessary and common practice — so the foundation could help patients afford their copays on a medically necessary treatment that staves off blindness. Regeneron was, essentially and entirely, simply paying Medicare.
Why is Regeneron so inaccessible to poor patients?
To make it inaccessible to poorer patients because they can’t afford the copay is to condemn them to get more injections in their eyes and/or to progress towards blindness. Regeneron’s so-called kickbacks are just leveling the playing field between rich and poor.
What does the Massachusetts state attorney's office say about Medicare copays?
attorney’s office in Massachusetts says that Medicare copays “encourage market forces to serve as a check on health care costs.”. That sounds rational enough.
Why did Regeneron donate money to charity?
So Regeneron donated money to a charity so it could help patients pay Medicare’s egregiously high out-of-pocket costs.
What is encouraging copay?
So what is this copay “encouraging” or nudging patients to do? The answer is simple: It makes someone think, “Do I really need this treatment?” The copay is there so you don’t “overuse” services your insurer (in this case Medicare) has to pay for.
Did Regeneron pay kickbacks?
L ast Wednesday, the Department of Justice filed suit against Regeneron for paying ” tens of millions of dollars in kickbacks ” through a foundation that helps patients cover copays associated with Eylea, its macular degeneration drug. Whether or not Regeneron broke the law, the suit illuminates the stupidity, cruelty, and counterproductivity of Medicare’s insistence that patients feel financial pain in order to receive medically necessary therapies.
Does Regeneron pay Medicare?
Regeneron was, essentially and entirely, simply paying Medicare. For patients with private insurance, drug companies provide copay assistance directly. Usually this assistance is in the form of a coupon or charge card designed specifically to reduce the patient’s out-of-pocket costs to something manageable.
What is the extra help program?from praluenthcp.com
It's called the Extra Help Program and it offers: Reduced Medicare Part D premiums. No cost share in the coverage gap or "donut hole". Lower drug copays.
How long does it take for a patient to get reimbursement for a copay?from praluenthcp.com
Patients can submit for reimbursement if they paid their copay in full within 90 days. || Eligible patients with commercial insurance not funded through a government healthcare. program such as Medicare, Medicaid, or TRICARE are subject to program terms and restrictions.
What is step therapy override?from praluent.com
Some states have laws called “step therapy override legislation” that may help certain people get access to specialty medications like PRALUENT. Not sure about the drug coverage in your state? You can find your state’s National Association of Insurance Commissioners contact information here.
What is the extra help program?from praluent.com
It's called the Extra Help Program and it offers: Reduced Medicare Part D premiums. No cost share in the coverage gap or "donut hole". Lower drug copays.
How long does it take for a patient to get reimbursement for a copay?from praluenthcp.com
Patients can submit for reimbursement if they paid their copay in full within 90 days. || Eligible patients with commercial insurance not funded through a government healthcare. program such as Medicare, Medicaid, or TRICARE are subject to program terms and restrictions.
What is step therapy override?from praluent.com
Some states have laws called “step therapy override legislation” that may help certain people get access to specialty medications like PRALUENT. Not sure about the drug coverage in your state? You can find your state’s National Association of Insurance Commissioners contact information here.
What to know before submitting documentation to health plan?from praluenthcp.com
Before submitting any documentation to the health plan, be sure that it’s accurate and up to date to avoid unnecessary denials.
Do you need a PA for paluent?from praluenthcp.com
Many health plans require a PA for PRALUENT. Here are some helpful tips to keep in mind when gathering your patient’s clinical information and preparing a PA submission.
What is nursing support?from dupixentmywayportal.com
Nursing support: A patient-centric approach to educating and empowering patients to use and stay on DUPIXENT
Who do I give supplemental injection training to?from dupixent.com
I give supplemental injection training to the patient and the patient’s caregiver.
What is a duplexent myway?from dupixent.com
DUPIXENT MyWay® is a patient support program designed to help you get access to DUPIXENT as quickly as possible and help you stay on track while providing helpful tools and resources.
Can you send out a duplexent insert?from dupixent.com
We have multiple resources available for patients. We have the ability to send out package inserts that include all the important safety information for DUPIXENT. For patients wanting a copay card, they can access that by visiting our product website at DUPIXENT.com.
Does Dupixent require insurance?from dupixent.com
Since DUPIXENT is a specialty medication, it may require additional approval from your insurance company and is typically shipped from a specialty pharmacy. Visit our Pricing and Insurance page to get more information on coverage, ordering through a specialty pharmacy, or cost.
What charity did Regeneron use to help patients?
In 2019, the charity that Regeneron used to operate its patient assistance program, the Chronic Disease Fund, paid $2 million to resolve allegations that it had served as a conduit to companies paying kickbacks to Medicare patients taking their drugs. That settlement involved its work with five other companies: Novartis, Dendreon, Astellas, Onyx, and Questcor. The charity, which has been renamed Good Days, did not respond to a request for comment.
Where is Regeneron located?
Regeneron’s offices in Tarrytown, N.Y. Credit... Suzanne DeChillo/The New York Times. By Katie Thomas. June 24, 2020. The drugmaker Regeneron funneled tens of millions of dollars to a charity that paid the out-of-pocket costs for patients who took the company’s expensive eye drug, then lied to internal auditors about it, ...
What is the Regeneron lawsuit?
District Court of Massachusetts in Boston, claims that Regeneron violated federal anti-kickback laws by using the patient-assistance fund to encourage doctors to prescribe their drug, Eylea, over a less-expensive competitor.
Is Regeneron under investigation?
Regeneron is the latest company to come under federal scrutiny for its use of charities to cover patients’ drug costs. In 2018, Johnson & Johnson agreed to pay $360 million to settle allegations that a company it had acquired, Actelion Pharmaceuticals, funneled illegal kickbacks through a charity. In 2017, United Therapeutics paid $210 million to settle similar allegations, and several other drugmakers have disclosed that they are also under investigation for their use of patient-assistance charities.
Who lied to Regeneron?
Prosecutors said that the company’s executives later lied to Regeneron’s own internal auditors who were investigating the company’s use of charitable assistance programs and denied directly discussing with the fund how much money would cover the cost of assistance for Eylea.
Is Eylea more affordable than Avastin?
As a result, the patient assistance program was integral to driving sales of Eylea, the prosecutors said, because it made Eylea more affordable than Avastin. In 2014, for example, when a large retina clinic heard that the Chronic Disease Fund may have run out of funds, it started “putting patients only on Avastin,” according to an email from a Regeneron sales representative that was included in the lawsuit.